Lakeview Capital Partners LLC decreased its position in Gilead Sciences, Inc. (NASDAQ:GILD) by 29.5% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,827 shares of the biopharmaceutical company’s stock after selling 1,599 shares during the period. Lakeview Capital Partners […]
Read More